| Company Name: | Healthways, Incorporated | | Ticker Symbol: | HWAY | | | WWW Address: | www.americanhealthways.com | | CEO: | Ben R. Leedle, Jr. | | No. of Employees: | 3,500 | | Common Issue Type: | CS | | Business Description: | The Company and its wholly-owned subsidiaries provide Health and Care Support solutions to help people maintain or improve their health and as a result, reduce overall healthcare costs.
|
| | | Industry Information: | HEALTH SERVICES - Specialized Health Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 17.2 |  0.42 | 14.5 | 30.0 | 17.04 | 17.78 | 16.92 | 94998 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 581.4 | 33.8 | 1.48 | 0.02 | 0.00 | 191.1 | 0.0 | 19.44 - 7.01 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 17.20 | $ | | PE Ratio - LTM | 191.1 | |
| Market Capitalisation | 581.3 | mil |
| Latest Shares Outstanding | 33.8 | mil |
| Earnings pS (EPS) | 0.02 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 69,925 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 32.5 | mil |
| Float as % of Shares Outstanding | 96.3 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 10.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 27.7 | % |
| EBITDA Margin | 17.6 | % |
| Pre-Tax Profit Margin | 1.6 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 0.3 | % |
| Return on Equity (ROE) | 0.8 | % |
| Return on Capital Invested (ROCI) | 0.5 | % |
| Current Ratio | 0.9 | |
| Leverage Ratio (Assets/Equity) | 2.4 | |
| Interest Cover | 1.7 | |
| Total Debt/Equity (Gearing Ratio) | 0.74 | |
| LT Debt/Total Capital | 42.0 | % |
| Working Capital pS | -0.76 | $ |
| Cash pS | 0.07 | $ |
| Book-Value pS | 10.84 | $ |
| Tangible Book-Value pS | -6.31 | $ |
| Cash Flow pS | 1.19 | $ |
| Free Cash Flow pS | 1.37 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.59 | |
| Price/Tangible Book Ratio | -2.73 | |
| Price/Cash Flow | 14.5 | |
| Price/Free Cash Flow | 12.6 | |
| P/E as % of Industry Group | 663.0 | % |
| P/E as % of Sector Segment | 821.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.5 | 101 | 1,445 | 865 |
| 4 Weeks | 17.98 | 15.61 | 16.08 | 7.0 | 100 | 1,535 | 24,558 |
| 13 Weeks | 19.44 | 12.79 | 13.25 | 29.8 | 121 | 2,176 | 130,541 |
| 26 Weeks | 19.44 | 11.89 | 11.97 | 43.7 | 119 | 2,229 | 276,408 |
| 52 Weeks | 19.44 | 7.01 | 8.09 | 112.6 | 172 | 3,191 | 791,446 |
| YTD | 19.44 | 7.01 | - | 49.8 | 122 | 3,140 | 709,742 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 17.31 | 17.02 | 16.36 | 14.30 | 12.91 | 1.48 | 1.59 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 6.21 | 6.8 | -10.52 |
| Income | -44.75 | 42.9 | -66.95 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -3.67 | NA | -31.75 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | -28.51 | NA | -53.10 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -0.7 | -5.1 | -66.8 |
| Earnings % | -92.4 | -37.0 | -98.7 |
| EPS % | -92.1 | -33.3 | -98.7 |
| EPS $ | -0.93 | -0.13 | -1.48 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -0.68 |
| Current Ratio | 1.0 |
| Quick Ratio (Acid Test) | 0.7 |
| Liquidity Ratio (Cash) | 0.03 |
| Receivables Turnover | 2.1 |
| Average Collection Period | 171 |
| Working Capital/Equity | -1.7 |
| Working Capital pS | -0.18 |
| Cash-Flow pS | 0.52 |
| Free Cash-Flow pS | 0.24 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 0.99 |
| Financial Leverage Ratio (Assets/Equity) | 2.5 |
| Debt Ratio | 59.6 |
| Total Debt/Equity (Gearing Ratio) | 0.87 |
| LT Debt/Equity | 0.85 |
| LT Debt/Capital Invested | 53.2 |
| LT Debt/Total Liabilities | 57.9 |
| Interest Cover | 1.3 |
| Interest/Capital Invested | 0.95 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 174.50 |
| Tobin's Q Ratio | 0.66 |
| Current P/E Ratio - LTM | 191.10 |
| Enterprise Value (EV)/EBITDA | 27.76 |
| Enterprise Value (EV)/Free Cash Flow | 103.07 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -2.73 |
| Price/Book Ratio - LTM | 1.59 |
| Price/Cash Flow Ratio | 14.5 |
| Price/Free Cash Flow Ratio - LTM | 12.6 |
| Price/Sales Ratio | 1.07 |
| P/E Ratio (1 month ago) - LTM | 205.4 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 5.4 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 12.4 |
| 5-Y Average P/E Ratio | 145.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 132 |
| P/E as % of Industry Group | 663.0 |
| P/E as % of Sector Segment | 821.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 191.1 |
| PER SHARE FIGURES |
| LT Debt pS | 9.04 |
| Current Liabilities pS | 5.17 |
| Tangible Book Value pS - LTM | -6.31 |
| Book Value pS - LTM | 10.84 |
| Capital Invested pS | 19.57 |
| Cash pS - LTM | 0.07 |
| Cash Flow pS - LTM | 1.19 |
| Free Cash Flow pS - LTM | 1.37 |
| Earnings pS (EPS) | 0.02 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 3.25 |
| Free Cash Flow Margin 5YEAR AVG | -5.02 |
| Net Profit Margin | 0.3 |
| Net Profit Margin - 5YEAR AVRG. | 7.4 |
| Equity Productivity | 0.69 |
| Return on Equity (ROE) | 0.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 11.0 |
| Capital Invested Productivity | 0.37 |
| Return on Capital Invested (ROCI) | 0.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 6.8 |
| Assets Productivity | 0.30 |
| Return on Assets (ROA) | 0.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 5.2 |
| Gross Profit Margin | 27.7 |
| Gross Profit Margin - 5YEAR AVRG. | 31.8 |
| EBITDA Margin - LTM | 17.6 |
| EBIT Margin - LTM | 3.8 |
| Pre-Tax Profit Margin | 0.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 12.3 |
| Effective Tax Rate | 57.9 |
| Effective Tax Rate - 5YEAR AVRG. | 43.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 169 |
| Revenue per Employee | 69,925 |
| Net Income per Employee | 210 |
| Average Collection Period | 169 |
| Receivables Turnover | 2.1 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 8.84 |
| Assets/Revenue | 3.33 |
| Net Working Capital Turnover | -40.56 |
| Fixed Assets Turnover | 0.34 |
| Total Assets Turnover | 0.3 |
| Revenue per $ Cash | 47.46 |
| Revenue per $ Plant | 2.20 |
| Revenue per $ Common Equity | 0.69 |
| Revenue per $ Capital Invested | 0.37 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 10.3 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |